← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2020Last known activity
Apr 30, 2026
Timeline
2000s
- Jan 1, 2005
PureTech— Founded
Drugs by trial phase (7 distinct, 8 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Recent trials (11)
- NCT07284602Lead sponsorPhase 3Apr 30, 2026
- NCT06717100Lead sponsorPhase 1Dec 31, 2024
- NCT05829226Lead sponsorPhase 1Dec 12, 2022
- NCT05829226Study directorPhase 1Dec 12, 2022
- NCT05321420Lead sponsorPhase 2Jul 29, 2022
- NCT05321420Study directorPhase 2Jul 29, 2022
- NCT05129865Lead sponsorPhase 1Dec 31, 2021
- NCT04666688Lead sponsorPhase 1/Phase 2Dec 31, 2020
- NCT04666688Study directorPhase 1/Phase 2Dec 31, 2020
- NCT04652518Lead sponsorPhase 2Dec 11, 2020
- NCT04243837Lead sponsorPhase 1Mar 1, 2020
Details
- Founded
- Boston, MA, US Jan 1, 2005
- Last known activity
- Apr 30, 2026